{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T03:03:41Z","timestamp":1794711821339,"version":"4.9.1"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T00:00:00Z","timestamp":1618531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Ministry of Health, Labour, and Welfare of Japan","award":["H30-menneki-shitei-002"],"award-info":[{"award-number":["H30-menneki-shitei-002"]}]},{"name":"Ministry of Health, Labour, and Welfare of Japan","award":["H30-menneki-shitei-002"],"award-info":[{"award-number":["H30-menneki-shitei-002"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To describe the clinicopathological characteristics of lymphoproliferative disorders (LPDs) in patients with rheumatoid arthritis (RA).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this multicenter case series, we retrospectively reviewed the medical records of RA patients who were newly diagnosed as having LPDs with or without biopsy confirmation between 2000 and 2017 in eight hospitals in Japan.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We included 232 patients with LPDs. The median age was 67 years (interquartile range [IQR], 60\u201373 years), and 77.1% were female. At the time of LPD diagnosis, 94.8% and 62.6% of the patients were methotrexate users and in remission or had low RA disease activity, respectively; lymphadenopathy and extranodal involvement were present in 77.1% and 51.9%, respectively. Major extranodal sites were the lungs and oral\/oropharyngeal mucosa. The most common LPD pathological subtype was diffuse large B-cell lymphoma (40.5%), followed by classic Hodgkin lymphoma (10.8%), Epstein\u2013Barr virus-positive mucocutaneous ulcer (7.7%), and reactive lymphoid hyperplasia (6.2%). The clinical and laboratory characteristics varied across the pathological subtypes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>LPD occurred mainly in methotrexate users, while RA disease activity did not seem to be associated with LPD development. Although the clinical manifestations vary among pathological subtypes, manifestations of LPD in patients with RA can include lymphadenopathy, extranodal mass, and mucocutaneous ulcer.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1080\/14397595.2021.1899570","type":"journal-article","created":{"date-parts":[[2021,3,11]],"date-time":"2021-03-11T19:02:44Z","timestamp":1615489364000},"page":"32-40","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["Clinicopathological characteristics of lymphoproliferative disorders in 232 patients with rheumatoid arthritis in Japan: A retrospective, multicenter, descriptive study"],"prefix":"10.1093","volume":"32","author":[{"given":"Hideto","family":"Takada","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Tokyo Women\u2019s Medical University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Kaneko","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Nakano","sequence":"additional","affiliation":[{"name":"The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Advanced Medicine for Rheumatic Diseases, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Fujii","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyoshi","family":"Saito","sequence":"additional","affiliation":[{"name":"Tobata General Hospital, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Sugimoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tokyo Women\u2019s Medical University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoh","family":"Sasaki","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Tokai University Hachioji Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuntaro","family":"Saito","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rintaro","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Kuramoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Wakayama Medical University, Wakayama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Harigai","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tokyo Women\u2019s Medical University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Tokai University Hachioji Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,4,16]]},"reference":[{"key":"2022010903470201600_R1","author":"Swerdlow","year":"2017"},{"issue":"1","key":"2022010903470201600_R2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2017.1352477","article-title":"Lymphoproliferative disorders in patients with rheumatoid arthritis in the era of widespread use of methotrexate: a review of the literature and current perspective","volume":"28","author":"Harigai","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"2","key":"2022010903470201600_R3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3960\/jslrt.19007","article-title":"Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"59","author":"Tokuhira","year":"2019","journal-title":"J Clin Exp Hematop"},{"issue":"3","key":"2022010903470201600_R4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/ijc.11582","article-title":"Lymphoproliferative disorders in autoimmune diseases in Japan: analysis of clinicopathological features and Epstein-Barr virus infection","volume":"108","author":"Hoshida","year":"2004","journal-title":"Int J Cancer"},{"issue":"9","key":"2022010903470201600_R5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.prp.2006.05.007","article-title":"Methtrexate-associated lymphoproliferative disorders. A clinicopathological study of 13 Japanese cases","volume":"202","author":"Kojima","year":"2006","journal-title":"Pathol Res Pract"},{"issue":"2","key":"2022010903470201600_R6","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3899\/jrheum.130270","article-title":"A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders","volume":"41","author":"Yamakawa","year":"2014","journal-title":"J Rheumatol"},{"issue":"12","key":"2022010903470201600_R7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1002\/ajh.21003","article-title":"Remission of lymphoma after withdrawal of methotrexate in rheumatoid arthritis: relationship with type of latent Epstein-Barr virus infection","volume":"82","author":"Miyazaki","year":"2007","journal-title":"Am J Hematol"},{"issue":"1","key":"2022010903470201600_R8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/ejh.12116","article-title":"Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression","volume":"91","author":"Ichikawa","year":"2013","journal-title":"Eur J Haematol"},{"issue":"4","key":"2022010903470201600_R9","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3109\/10428194.2011.625101","article-title":"Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis","volume":"53","author":"Tokuhira","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"2022010903470201600_R10","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1080\/10428194.2017.1369073","article-title":"Clinicopathologic investigation of methotrexate-induced lymphoproliferative disorders, with a focus on regression","volume":"59","author":"Tokuhira","year":"2018","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"2022010903470201600_R11","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1080\/10428194.2019.1585841","article-title":"Clinicopathological features of clinical methotrexate-related lymphoproliferative disorders","volume":"60","author":"Tokuhira","year":"2019","journal-title":"Leuk Lymphoma"},{"issue":"6","key":"2022010903470201600_R12","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/rheumatology\/kex002","article-title":"Distinct patterns of lymphocyte count transition in lymphoproliferative disorder in patients with rheumatoid arthritis treated with methotrexate","volume":"56","author":"Saito","year":"2017","journal-title":"Rheumatology"},{"issue":"4","key":"2022010903470201600_R13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/14397595.2017.1387223","article-title":"Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome","volume":"28","author":"Tsukui","year":"2018","journal-title":"Mod Rheumatol"},{"issue":"5","key":"2022010903470201600_R14","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/14397595.2019.1675260","article-title":"Pathological assessment of the lymph node biopsies for lymphadenopathy in rheumatoid arthritis","volume":"30","author":"Yamada","year":"2020","journal-title":"Mod Rheumatol"},{"issue":"1","key":"2022010903470201600_R15","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1080\/14397595.2020.1741870","article-title":"Clinical aspects in patients with rheumatoid arthritis complicated with lymphoproliferative disorders without regression after methotrexate withdrawal and treatment for arthritis after regression of lymphoproliferative disorders","volume":"31","author":"Nakano","year":"2020","journal-title":"Mod Rheumatol."},{"issue":"7","key":"2022010903470201600_R16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/PAS.0000000000001271","article-title":"Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: clinicopathologic features and prognostic factors","volume":"43","author":"Kurita","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"2022010903470201600_R17","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res."},{"key":"2022010903470201600_R18","author":"DAS-score website"},{"issue":"1","key":"2022010903470201600_R19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2019.1660028","article-title":"A large observational cohort study of rheumatoid arthritis, IORRA: providing context for today's treatment options","volume":"30","author":"Yamanaka","year":"2020","journal-title":"Mod Rheumatol"},{"issue":"9","key":"2022010903470201600_R20","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1136\/ard.2006.063834","article-title":"Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan","volume":"66","author":"Matsui","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"2022010903470201600_R21","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/art.21675","article-title":"Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis","volume":"54","author":"Baecklund","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"2022010903470201600_R22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/art.40017","article-title":"Rheumatoid arthritis and risk of malignant lymphoma: is the risk still increased?","volume":"69","author":"Hellgren","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2022010903470201600_R23","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/bjh.15263","article-title":"Management of post-transplant lymphoproliferative disorders","volume":"182","author":"DeStefano","year":"2018","journal-title":"Br J Haematol"},{"issue":"3","key":"2022010903470201600_R24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PAS.0b013e3181cf8622","article-title":"EBV positive mucocutaneous ulcer-a study of 26 cases associated with various sources of immunosuppression","volume":"34","author":"Dojcinov","year":"2010","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"2022010903470201600_R25","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s12105-012-0380-5","article-title":"Hodgkin lymphoma of the oral mucosa","volume":"6","author":"Darling","year":"2012","journal-title":"Head Neck Pathol"},{"issue":"3","key":"2022010903470201600_R26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/ard.27.3.253","article-title":"Rheumatoid lymphadenopathy","volume":"27","author":"Robertson","year":"1968","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"2022010903470201600_R27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/147323000303100415","article-title":"Frequency of lymphadenopathy in rheumatoid arthritis and systemic lupus erythematosus","volume":"31","author":"Calg\u00fcneri","year":"2003","journal-title":"J Int Med Res"},{"issue":"6","key":"2022010903470201600_R28","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00296-018-3992-6","article-title":"CT assessment of axillary lymphadenopathy in patients with rheumatoid arthritis: association with disease activity and severity","volume":"38","author":"Hasegawa","year":"2018","journal-title":"Rheumatol Int"},{"issue":"3","key":"2022010903470201600_R29","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1182\/blood-2013-03-489708","article-title":"EBV-positive diffuse large B-cell lymphoma of the elderly","volume":"122","author":"Ok","year":"2013","journal-title":"Blood"}],"container-title":["Modern Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/mr\/advance-article-pdf\/doi\/10.1080\/14397595.2021.1899570\/41812177\/1899570.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/1\/32\/42083360\/1899570.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/mr\/article-pdf\/32\/1\/32\/42083360\/1899570.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T02:56:08Z","timestamp":1642560968000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mr\/article\/32\/1\/32-40\/6468899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,16]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,4,16]]},"published-print":{"date-parts":[[2022,1,5]]}},"URL":"https:\/\/doi.org\/10.1080\/14397595.2021.1899570","relation":{},"ISSN":["1439-7595","1439-7609"],"issn-type":[{"value":"1439-7595","type":"print"},{"value":"1439-7609","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,1,1]]},"published":{"date-parts":[[2021,4,16]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=imor20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2020-08-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-02-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}